Search results
Results from the WOW.Com Content Network
A parasympathomimetic drug, sometimes called a cholinomimetic drug [1] or cholinergic receptor stimulating agent, [2] is a substance that stimulates the parasympathetic nervous system (PSNS).
Insulin detemir works by increasing the amount of glucose absorbed by tissues and reducing the amount of glucose produced by the liver. [75] Insulin detemir was approved for medical use in the European Union in June 2004 and in the United States in June 2005. [77] [75] [78] It is listed on the World Health Organization's List of Essential ...
dextrose 5% in normal saline (0.9%) (intravenous sugar solution) D5W, D 5 W dextrose 5% in water (intravenous sugar solution) D10W, D 10 W dextrose 10% in water (intravenous sugar solution) da da: give DAW dispense as written (i.e., no generic substitution) DC, dc, D/C, disc discontinue [or] discharge ambiguous meaning decoct.
This is the first class of non-opioid pain medication approved to treat moderate to severe acute pain approved by the FDA in more than 20 years. The U.S. Food and Drug Administration (FDA) on ...
non–rapid eye movement: NRT nicotine replacement therapy: n.s. not significant: NS: normal saline: NSA: no significant abnormality NSAID: nonsteroidal antiinflammatory drug: NSBB: Non-selective beta blocker: NSCC: Non-squamous-cell carcinoma NSCLC: non–small cell lung carcinoma: NSD: normal spontaneous delivery (see childbirth) NSE ...
Metformin is the simplest non-insulin diabetes medication approved for use during pregnancy because it cannot cause hypoglycemia. Still, research on the long-term effects on children born to women ...
Non-steroidal anti-inflammatory drugs [1] [3] (NSAID) [1] are members of a therapeutic drug class which reduces pain, [4] decreases inflammation, decreases fever, [1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds ...
Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood.With the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.